STRICTLY CONFIDENTIAL
Exhibit 1.1
February 16, 2017
STRICTLY CONFIDENTIAL
Omer Xxxxxxxxxx Xxxx, Xx. 0X X.X. Xxx 0000 Xxxx 0000000, Xxxxxx |
Attn: Xxxxxxxxxxx Xxxxxxx, Chief Executive Officer
Dear Xx. Xxxxxxx:
This letter agreement (this “Agreement”) constitutes the agreement between Medigus Ltd. (the “Company”) and Xxxxxx & Xxxxxxx, a unit of X.X. Xxxxxxxxxx & Co., LLC (“Xxxxxx”), that Xxxxxx shall serve as the exclusive agent, advisor or underwriter in any offering (each, an “Offering”) of equity securities of the Company in the U.S. (“Securities”) during the Term (as defined below) of this Agreement. The terms of each Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Xxxxxx and nothing herein implies that Xxxxxx would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Xxxxxx’x assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Xxxxxx xxxxx appropriate under the circumstances and to the receipt of all internal approvals of Xxxxxx in connection with the transaction. The Company expressly acknowledges and agrees that Xxxxxx’x involvement in an Offering is strictly on a reasonable best efforts basis and that the consummation of an Offering will be subject to, among other things, market conditions. The execution of this Agreement does not constitute a commitment by Xxxxxx to purchase the Securities and does not ensure a successful Offering of the Securities or the success of Xxxxxx with respect to securing any other financing on behalf of the Company. Xxxxxx may retain other brokers, dealers, agents or underwriters on its behalf in connection with an Offering.
A. Compensation; Reimbursement. At the closing of each Offering (each, a “Closing”), the Company shall compensate Xxxxxx as follows:
1. Cash Fee. The Company shall pay to Rodman a cash fee, or as to an underwritten Offering an underwriter discount, equal to (A) 7.0% of the aggregate gross proceeds raised in each Offering and (B) 4.0% of the aggregate gross proceeds raised in each offering from Pre-Existing Investors. As used herein, “Pre-Existing Investors” means Orbimed, Xxxxxx, or any affiliates thereof.
000 Xxxx Xxxxxx x Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500
Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC
2. Warrant Coverage. The Company shall issue to Xxxxxx or its designees at each Closing, warrants (the “Xxxxxx Warrants”) to purchase that number of ordinary shares of the Company equal to 7% of the aggregate number of ordinary shares placed in each Offering (and if the Securities are convertible or include a “greenshoe” or “additional investment” option component, such number of ordinary shares underlying such Securities or options, with the warrant issuable upon conversion of the Securities or the exercise of the option). If the Securities included in an Offering are non-convertible, the Xxxxxx Warrants shall be determined by dividing the gross proceeds raised in such Offering from investors divided by the then market price of the Company’s ordinary shares. The Xxxxxx Warrants shall have the same terms as the warrants issued to investors in the applicable Offering, except that such Xxxxxx Warrant shall have an exercise price equal to 125% of the public offering price per share in the applicable Offering. If no warrants are issued to investors in an Offering, the Xxxxxx Warrants shall be in a customary form reasonably acceptable to Xxxxxx, have a term of 5 years and an exercise price equal to 125% of the then market price of the Company’s ordinary shares.
3. Expense Allowance. Out of the proceeds of each Closing, the Company also agrees to pay Xxxxxx (a) a management fee equal to 1.0% of the gross proceeds raised in each Offering; (b) $40,000 for non-accountable expenses; plus (c) up to $100,000 for legal fees and expenses; plus the additional reimbursable amount payable by the Company pursuant to Section D.3 below; provided, however, that such reimbursement amount in no way limits or impairs the indemnification and contribution provisions of this Agreement. Upon the execution of this Agreement, the Company shall advance Xxxxxx the sum of $25,000 against legal fees and expenses anticipated to be incurred, subject to reimbursement by Xxxxxx to the Company if not actually incurred, in accordance with FINRA Rule 5110(f)(2)(C) and (f)(2)(D). Such sum shall be credited against the legal fees and expenses incurred by Xxxxxx in the case of a completed Offering.
4. Tail Fee. Xxxxxx shall be entitled to compensation under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom Xxxxxx had contacted during the Term, or introduced, directly or indirectly, to the Company during Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement. A list of the investors covered in the Tail Financing fee will be set forth in Exhibit I upon termination or expiration of this Agreement.
5. Right of First Refusal. Provided this Agreement in not terminated by Xxxxxx and that an Offering is consummated during the Term, then, if, from the date hereof until the 12-month anniversary following consummation of each Offering, the Company or any of its subsidiaries decides to raise funds by means of a public offering or a private placement of equity or debt securities using an underwriter or placement agent in the U.S., Xxxxxx (or any affiliate designated by Xxxxxx) shall have the right of first refusal to act as lead underwriter or lead placement agent for such financing, provided that Xxxxxx will provide its consent to act as an underwriter or placement agent within five (5) business days following the Company’s notice. If Xxxxxx or one of its affiliates decides to accept any such engagement, the agreement governing such engagement will contain, among other things, provisions for customary fees for transactions of similar size and nature and the provisions of this Agreement, including indemnification, which are appropriate to such a transaction, in each case in form and manner reasonably acceptable to the Company.
| 2 |
B. Term and Termination of Engagement; Exclusivity. The term of Xxxxxx’x exclusive engagement will begin on the date hereof and three (3) months thereafter (the “Term”). Notwithstanding anything to the contrary contained herein, the Company agrees that the provisions relating to the payment of fees, reimbursement of expenses, right of first refusal, tail, indemnification and contribution, confidentiality, conflicts, independent contractor and waiver of the right to trial by jury will survive any termination of this Agreement. During Xxxxxx’x engagement hereunder: (i) the Company will not, and will not permit its representatives to, other than in coordination with Xxxxxx, contact or solicit institutions, corporations or other entities or individuals as potential purchasers of the Securities in the U.S. and (ii) the Company will not pursue any financing transaction which would be in lieu of an Offering (for the purpose of this clause (ii), a transaction in China or with a strategic partner will not be deemed a financing transaction which would be in lieu of an Offering). Furthermore, the Company agrees that during Xxxxxx’x engagement hereunder, all inquiries, whether direct or indirect, from prospective investors in the U.S. will be referred to Xxxxxx and will be deemed to have been contacted by Xxxxxx in connection with an Offering. Additionally, except as set forth hereunder, the Company represents, warrants and covenants that no brokerage or finder’s fees or commissions are or will be payable by the Company or any subsidiary of the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other third-party with respect to any Offering.
C. Information; Reliance. The Company shall furnish, or cause to be furnished, to Xxxxxx all information requested by Xxxxxx for the purpose of rendering services hereunder and conducting due diligence (all such information being the “Information”). In addition, the Company agrees to make available to Xxxxxx upon request from time to time the officers, directors, accountants, counsel and other advisors of the Company. The Company recognizes and confirms that Xxxxxx (a) will use and rely on the Information, including any documents provided to investors in each Offering (the “Offering Documents” which shall include any Purchase Agreements (as defined below)), and on information available from generally recognized public sources in performing the services contemplated by this Agreement without having independently verified the same; (b) does not assume responsibility for the accuracy or completeness of the Offering Documents or the Information and such other information; and (c) will not make an appraisal of any of the assets or liabilities of the Company. Upon reasonable request, the Company will meet with Xxxxxx or its representatives to discuss all information relevant for disclosure in the Offering Documents and will cooperate in any investigation undertaken by Xxxxxx thereof, including any document included or incorporated by reference therein. At each Offering, at the request of Xxxxxx, the Company shall deliver such legal letters (including, without limitation, negative assurance letters), opinions, comfort letters and officers’ and secretary certificates and good standing certificates, all in form and substance satisfactory to Xxxxxx and its counsel as is customary for such Offering. Xxxxxx shall be a third party beneficiary of any representations, warranties, covenants and closing conditions made by the Company in any Offering Documents, including representations, warranties, covenants and closing conditions made to any investor in an Offering.
| 3 |
D. Related Agreements. At each Offering, the Company shall enter into the following additional agreements:
1. Underwritten Offering. If an Offering is an underwritten Offering, the Company and Xxxxxx shall enter into a customary underwriting agreement in form and substance satisfactory to Xxxxxx and its counsel.
2. Best Efforts Offering. If an Offering is on a best efforts basis, the sale of Securities to the investors in the Offering will be evidenced by a purchase agreement (“Purchase Agreement”) between the Company and such investors in a form reasonably satisfactory to the Company and Xxxxxx. Xxxxxx shall be a third party beneficiary with respect to the representations and warranties included in the Purchase Agreement. Prior to the signing of any Purchase Agreement, officers of the Company with responsibility for financial affairs will be available to answer inquiries from prospective investors.
3. Escrow and Settlement. In respect of each Offering, the Company and Xxxxxx shall enter into an escrow agreement with a third party escrow agent, which may also be Xxxxxx’x clearing agent, pursuant to which Xxxxxx’x compensation and expenses shall be paid from the gross proceeds of the Securities sold. If the Offering is settled in whole or in part via delivery versus payment (“DVP”), Xxxxxx shall arrange for its clearing agent to provide the funds to facilitate such settlement. The Company shall bear the cost of the escrow agent and shall reimburse Xxxxxx for the actual out-of-pocket cost of such clearing agent settlement and financing, if any, which cost shall not exceed $10,000.
4. FINRA Amendments. Notwithstanding anything herein to the contrary, in the event that Xxxxxx determines that any of the terms provided for hereunder shall not comply with a FINRA rule, including but not limited to FINRA Rule 5110, then the Company shall agree to amend this Agreement (or include such revisions in the final underwriting) in writing upon the request of Xxxxxx to comply with any such rules; provided that any such amendments shall not provide for terms that are less favorable to the Company than are reflected in this Agreement.
E. Confidentiality. In the event of the consummation or public announcement of any Offering, Xxxxxx shall have the right to disclose its participation in such Offering, including, without limitation, the Offering at its cost of “tombstone” advertisements in financial and other newspapers and journals.
| 4 |
F. Indemnity.
1. In connection with the Company’s engagement of Xxxxxx as Offering agent, the Company hereby agrees to indemnify and hold harmless Xxxxxx and its affiliates, and the respective controlling persons, directors, officers, members, shareholders, agents and employees of any of the foregoing (collectively the “Indemnified Persons”), from and against any and all claims, actions, suits, proceedings (including those of shareholders), damages, liabilities and expenses incurred by any of them (including the reasonable fees and expenses of counsel), as incurred, (collectively a “Claim”), that are (A) related to or arise out of (i) any actions taken or omitted to be taken (including any untrue statements made or any statements omitted to be made) by the Company, or (ii) any actions taken or omitted to be taken by any Indemnified Person in connection with the Company’s engagement of Xxxxxx, or (B) otherwise relate to or arise out of Xxxxxx’x activities on the Company’s behalf under Xxxxxx’x engagement, and the Company shall reimburse any Indemnified Person for all expenses (including the reasonable fees and expenses of counsel) as incurred by such Indemnified Person in connection with investigating, preparing or defending any such claim, action, suit or proceeding, whether or not in connection with pending or threatened litigation in which any Indemnified Person is a party. The Company will not, however, be responsible for any Claim that is finally judicially determined to have resulted from the fraud, gross negligence or willful misconduct of any person seeking indemnification for such Claim. The Company further agrees that no Indemnified Person shall have any liability to the Company for or in connection with the Company’s engagement of Xxxxxx except for any Claim incurred by the Company as a result of such Indemnified Person’s fraud, gross negligence or willful misconduct.
2. The Company further agrees that it will not, without the prior written consent of Rodman, settle, compromise or consent to the entry of any judgment in any pending or threatened Claim in respect of which indemnification may be sought hereunder (whether or not any Indemnified Person is an actual or potential party to such Claim), unless such settlement, compromise or consent includes an unconditional, irrevocable release of each Indemnified Person from any and all liability arising out of such Claim.
3. Promptly upon receipt by an Indemnified Person of notice of any complaint or the assertion or institution of any Claim with respect to which indemnification is being sought hereunder, such Indemnified Person shall notify the Company in writing of such complaint or of such assertion or institution but failure to so notify the Company shall not relieve the Company from any obligation it may have hereunder, except and only to the extent such failure results in the forfeiture by the Company of substantial rights and defenses. If the Company so elects or is requested by such Indemnified Person, the Company will assume the defense of such Claim, including the employment of counsel reasonably satisfactory to such Indemnified Person and the payment of the fees and expenses of such counsel. In the event, however, that legal counsel to such Indemnified Person reasonably determines that having common counsel would present such counsel with a conflict of interest or if the defendant in, or target of, any such Claim, includes an Indemnified Person and the Company, and legal counsel to such Indemnified Person reasonably concludes that there may be legal defenses available to it or other Indemnified Persons different from or in addition to those available to the Company, then such Indemnified Person may employ its own separate counsel to represent or defend him, her or it in any such Claim and the Company shall pay the reasonable fees and expenses of such counsel. Notwithstanding anything herein to the contrary, if the Company fails timely or diligently to defend, contest, or otherwise protect against any Claim, the relevant Indemnified Party shall have the right, but not the obligation, to defend, contest, compromise, settle, assert crossclaims, or counterclaims or otherwise protect against the same, and shall be fully indemnified by the Company therefor, including without limitation, for the reasonable fees and expenses of its counsel and all amounts paid as a result of such Claim or the compromise or settlement thereof. In addition, with respect to any Claim in which the Company assumes the defense, the Indemnified Person shall have the right to participate in such Claim and to retain his, her or its own counsel therefor at his, her or its own expense.
| 5 |
4. The Company agrees that if any indemnity sought by an Indemnified Person hereunder is held by a court to be unavailable for any reason then (whether or not Xxxxxx is the Indemnified Person), except to the extent that any such loss, claim, damage or liability is found in a final, non-appealable judgment by a court of competent jurisdiction to have resulted primarily from the Indemnified Person’s fraud, willful misconduct or gross negligence, the Company and Xxxxxx shall contribute to the Claim for which such indemnity is held unavailable in such proportion as is appropriate to reflect the relative benefits to the Company, on the one hand, and Xxxxxx on the other, in connection with Xxxxxx’x engagement referred to above, subject to the limitation that in no event shall the amount of Xxxxxx’x contribution to such Claim exceed the amount of fees actually received by Xxxxxx from the Company pursuant to Xxxxxx’x engagement. The Company hereby agrees that the relative benefits to the Company, on the one hand, and Xxxxxx on the other, with respect to Xxxxxx’x engagement shall be deemed to be in the same proportion as (a) the total value paid or proposed to be paid or received by the Company pursuant to the applicable Offering (whether or not consummated) for which Xxxxxx is engaged to render services bears to (b) the fee paid or proposed to be paid to Xxxxxx in connection with such engagement.
5. The Company’s indemnity, reimbursement and contribution obligations under this Agreement (a) shall be in addition to, and shall in no way limit or otherwise adversely affect any rights that any Indemnified Party may have at law or at equity and (b) shall be effective whether or not the Company is at fault in any way.
G. Limitation of Engagement to the Company. The Company acknowledges that Xxxxxx has been retained only by the Company, that Xxxxxx is providing services hereunder as an independent contractor (and not in any fiduciary or agency capacity) and that the Company’s engagement of Xxxxxx is not deemed to be on behalf of, and is not intended to confer rights upon, any shareholder, owner or partner of the Company or any other person not a party hereto as against Xxxxxx or any of its affiliates, or any of its or their respective officers, directors, controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), employees or agents. Unless otherwise expressly agreed in writing by Xxxxxx, no one other than the Company is authorized to rely upon this Agreement or any other statements or conduct of Xxxxxx, and no one other than the Company is intended to be a beneficiary of this Agreement. The Company acknowledges that any recommendation or advice, written or oral, given by Xxxxxx to the Company in connection with Xxxxxx’x engagement is intended solely for the benefit and use of the Company’s management and directors in considering a possible Offering, and any such recommendation or advice is not on behalf of, and shall not confer any rights or remedies upon, any other person or be used or relied upon for any other purpose. Xxxxxx shall not have the authority to make any commitment binding on the Company. The Company, in its sole discretion, shall have the right to reject any investor introduced to it by Xxxxxx.
| 6 |
H. Limitation of Xxxxxx’x Liability to the Company. Xxxxxx and the Company further agree that neither Xxxxxx nor any of its affiliates or any of its their respective officers, directors, controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act), employees or agents shall have any liability to the Company, its security holders or creditors, or any person asserting claims on behalf of or in the right of the Company (whether direct or indirect, in contract, tort, for an act of negligence or otherwise) for any losses, fees, damages, liabilities, costs, expenses or equitable relief arising out of or relating to this Agreement or the services rendered hereunder, except for losses, fees, damages, liabilities, costs or expenses that arise out of or are based on any action of or failure to act by Xxxxxx and that are finally judicially determined to have resulted solely from the fraud, gross negligence or willful misconduct of Xxxxxx.
I. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be fully performed therein. Any disputes that arise under this Agreement, even after the termination of this Agreement, will be heard only in the state or federal courts located in the City of New York, State of New York. The parties hereto expressly agree to submit themselves to the jurisdiction of the foregoing courts in the City of New York, State of New York. The parties hereto expressly waive any rights they may have to contest the jurisdiction, venue or authority of any court sitting in the City and State of New York. In the event Xxxxxx or any Indemnified Person is successful in any action, or suit against the Company, arising out of or relating to this Agreement, the final judgment or award entered shall be entitled to have and recover from the Company the costs and expenses incurred in connection therewith, including its reasonable attorneys’ fees. Any rights to trial by jury with respect to any such action, proceeding or suit are hereby waived by Xxxxxx and the Company.
J. Notices. All notices hereunder will be in writing and sent by certified mail, hand delivery, overnight delivery or fax, if sent to Xxxxxx, at the address set forth on the first page hereof, e-mail: xxxxxxx@xxxx.xxx, Attention: Head of Investment Banking, and if sent to the Company, to the address set forth on the first page hereof, e-mail: xxxxx.xxxxxxx@xxxxxxx.xxx, Attention: Chief Executive Officer. Notices sent by certified mail shall be deemed received five days thereafter, notices sent by hand delivery or overnight delivery shall be deemed received on the date of the relevant written record of receipt, notices delivered by fax shall be deemed received as of the date and time printed thereon by the fax machine and notices sent by e-mail shall be deemed received as of the date and time they were sent.
K. Conflicts. The Company acknowledges that Xxxxxx and its affiliates may have and may continue to have investment banking and other relationships with parties other than the Company pursuant to which Xxxxxx may acquire information of interest to the Company. Xxxxxx shall have no obligation to disclose such information to the Company or to use such information in connection with any contemplated transaction.
L. Anti-Money Laundering. To help the United States government fight the funding of terrorism and money laundering, the federal laws of the United States requires all financial institutions to obtain, verify and record information that identifies each person with whom they do business. This means we must ask you for certain identifying information, including a government-issued identification number (e.g., a U.S. taxpayer identification number) and such other information or documents that we consider appropriate to verify your identity, such as certified articles of incorporation, a government-issued business license, a partnership agreement or a trust instrument.
M. Miscellaneous. The Company represents and warrants that it has all requisite power and authority to enter into and carry out the terms and provisions of this Agreement and the execution, delivery and performance of this Agreement does not breach or conflict with any agreement, document or instrument to which it is a party or bound. This Agreement shall not be modified or amended except in writing signed by Xxxxxx and the Company. This Agreement shall be binding upon and inure to the benefit of both Xxxxxx and the Company and their respective assigns, successors, and legal representatives. This Agreement constitutes the entire agreement of Xxxxxx and the Company with respect to the subject matter hereof and supersedes any prior agreements with respect to the subject matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will not affect such provision in any other respect, and the remainder of the Agreement shall remain in full force and effect. This Agreement may be executed in counterparts (including facsimile or electronic counterparts), each of which shall be deemed an original but all of which together shall constitute one and the same instrument.
*********************
| 7 |
In acknowledgment that the foregoing correctly sets forth the understanding reached by Xxxxxx and the Company, please sign in the space provided below, whereupon this letter shall constitute a binding Agreement as of the date indicated above.
| Very truly yours, | |||||
| XXXXXX & XXXXXXX, A UNIT OF X.X. XXXXXXXXXX & CO., LLC | |||||
| By: | |||||
| Name: | |||||
| Title: | |||||
| Accepted and Agreed: | |||||
| MEDIGUS LTD. | |||||
| By: | |||||
| Name: | |||||
| Title: | |||||
| 8 |
March 22, 2017
STRICTLY CONFIDENTIAL
Omer Xxxxxxxxxx Xxxx, Xx. 0X X.X. Xxx 0000 Xxxx 0000000, Xxxxxx |
Attn: Xxxxxxxxxxx Xxxxxxx, Chief Executive Officer
Dear Xx. Xxxxxxx:
Reference is made to the engagement agreement (the “Engagement Agreement”), dated February 16, 2017, by and between Medigus Ltd. (the “Company”) and Xxxxxx & Xxxxxxx, a unit of X.X. Xxxxxxxxxx & Co., LLC (“Xxxxxx”), pursuant to which Xxxxxx shall serve as the exclusive agent, advisor or underwriter of the Company in connection with an Offering (as defined in the Engagement Agreement).
The Company and Xxxxxx hereby agree to amend Section A.4, Section A.5 and Section B of the Engagement Agreement.
As such, Section A.4 is hereby amended and restated in its entirety to read as follows:
Tail Fee. Xxxxxx shall be entitled to compensation under clauses (1) and (2) hereunder, calculated in the manner set forth therein, with respect to any public or private offering or other financing or capital-raising transaction of any kind (“Tail Financing”) to the extent that such financing or capital is provided to the Company by investors whom Xxxxxx had contacted or introduced, directly to the Company during Term, if such Tail Financing is consummated at any time within the 12-month period following the expiration or termination of this Agreement; A list of the investors covered in the Tail Financing fee will be set forth in Exhibit I upon termination or expiration of this Agreement. Notwithstanding anything to the contrary included in this Agreement, the Company shall have the right to terminate the Agreement for cause, in which case Xxxxxx’x right for the tail fee shall be eliminated in compliance with FINRA Rule 5110(f)(2)(D).
As such, Section A.5 is hereby amended and restated in its entirety to read as follows:
Right of First Refusal. Provided this Agreement is not terminated by Xxxxxx and that an Offering is consummated during the Term, then, if within the 12-month period following the commencement of sales in each Offering, the Company or any of its subsidiaries decides to raise funds by means of a public offering or a private placement of equity or debt securities using an underwriter or placement agent in the U.S., Xxxxxx (or any affiliate designated by Xxxxxx) shall have the right of first refusal to act as lead underwriter or lead placement agent for such financing, provided that Xxxxxx will provide its consent to act as an underwriter or placement agent within five (5) business days following the Company’s notice. If Xxxxxx or one of its affiliates decides to accept any such engagement, the agreement governing such engagement will contain, among other things, provisions for customary fees for transactions of similar size and nature and the provisions of this Agreement, including indemnification, which are appropriate to such a transaction, in each case in form and manner reasonably acceptable to the Company.
As such, the second and fourth sentences of Section B are hereby amended and restated in their entirety to read as follows:
Notwithstanding anything to the contrary contained herein, the Company agrees that the provisions relating to the payment of fees, reimbursement of expenses, right of first refusal, tail (subject to the Company’s right to terminate the Agreement for cause in compliance with FINRA Rule 5110(f)(2)(D)), indemnification and contribution, confidentiality, conflicts, independent contractor and waiver of the right to trial by jury will survive any termination of this Agreement.
Furthermore, the Company agrees that during Xxxxxx’x engagement hereunder, all direct inquiries from prospective investors in the U.S. will be referred to Xxxxxx and will be deemed to have been contacted by Xxxxxx in connection with an Offering.
Except as expressly set forth above, all of the terms and conditions of the Engagement Agreement shall continue in full force and effect after the execution of this agreement and shall not be in any way changed, modified or superseded by the terms set forth herein. Defined terms used herein but not defined herein shall have the meanings given to such terms in the Engagement Agreement.
This agreement may be executed in two or more counterparts and by facsimile or “.pdf” signature or otherwise, and each of such counterparts shall be deemed an original and all of such counterparts together shall constitute one and the same agreement.
[Remainder of page intentionally blank]
000 Xxxx Xxxxxx x Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500
Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC
| 9 |
IN WITNESS WHEREOF, this agreement is executed as of the date first set forth above.
| Very truly yours, | |||||
| XXXXXX & XXXXXXX, A UNIT OF X.X. XXXXXXXXXX & CO., LLC | |||||
| By: | |||||
| Name: | |||||
| Title: | |||||
| Accepted and Agreed: | |||||
| MEDIGUS LTD. | |||||
| By: | |||||
| Name: | |||||
| Title: | |||||
000 Xxxx Xxxxxx x Xxx Xxxx, Xxx Xxxx 00000 | 212.356.0500
Security services provided by X.X. Xxxxxxxxxx & Co., LLC | Member: FINRA/SIPC
